Jeb Bush and Martin O’Malley on Reopening After COVID-19

The first vaccines in the United States were given in December 2020, followed by the rollout of what is probably the largest immunization campaign in history. Since that time, approximately 150,424,675 or 45% of Americans have been immunized. In May, President Biden set the goal of delivering at least one shot to 70% of adult […]

Assessing the Impact of the EU’s Taxonomy Regulation

In effect since July 2020, the European Union’s Taxonomy is a classification system that provides a common language for what is environmentally sustainable. It is intended for financial products that have environmental sustainability as their objective or that promote their environmental characteristics. To understand what effect the Taxonomy is having on those products, on issuers […]

Biden’s Healthcare Priorities

On March 9, 2021, GLG ran its quarterly Virtual Healthcare Leadership Convene. GLG clients heard from our Network Member experts about a range of topics that included the state of COVID-19 in Europe and the practical fundamentals of diversity, equity, and inclusion, and President Biden’s healthcare agenda. Highlights of the final session, The Outlook for […]

Thoughts on Merrick Garland and the Biden DOJ

Merrick Garland was confirmed as Attorney General in March 2021. During his confirmation hearings, Garland said that he would prioritize fighting extremist violence, starting with the January 6, 2021, storming of the U.S. Capitol. In this article, Chuck Rosenberg gives his perspective on the Department of Justice’s independence, along with a clear picture of Garland’s […]

GLG’s Signature Series: Dr. Robert Gates, Former Secretary of Defense

Recently, GLG sat down for a 60-minute discussion with Dr. Robert Gates, Former Secretary of Defense, for a virtual session with select GLG clients. Dr. Gates served as U.S. Secretary of Defense from December 2006 to July 2011. He was the only Secretary of Defense in U.S. history asked to remain in that office by […]

What Does the Future Hold for the GOP after Trump?

President Donald Trump’s time as president ended with the shocking January 6 riot that saw pro-Trump demonstrators breach the Capitol building, shocking people on both sides of the political spectrum. Meanwhile, both Republican senators in Georgia lost their elections. With all this, what does the future hold for the GOP? GLG spoke to Scott Jennings, […]

GLG Close-Up on Incoming Biden Staffers

Joe Biden’s administration will undoubtedly chart a different path for America than the previous administration. Biden has served many years in public service, and to tackle the many challenges ahead, he has been assembling a seasoned staff of experts to address them, many of whom served in the Obama administration. As President Biden assumes office, […]

After the Big Tech Senate Hearing, Is Section 230 Likely to Change?

Twitter, Facebook, and Google CEOs testified before the Senate Commerce Committee in late October — the latest in a bipartisan effort to moderate online content without violating the First Amendment. But the hearing was nothing if not political. Twitter came under fire for policing content from President Trump more aggressively than other world leaders, and […]

The Post-Election Outlook for U.S.-China Economic, Business, and Trading Relations

America’s relationship with China, now often marked by tension, is likely to be reassessed under the incoming Biden administration. To discuss how U.S.-China relations may evolve, GLG recently met with China expert David Dollar, currently a Senior Fellow in the John L. Thornton China Center at the Brookings Institution. From 2009 to 2013, Dollar was […]

The Election of Joe Biden: Republican Perspective

[Ed. Note: GLG held a teleconference with Dave Hoppe titled “Post-Election Legislative Priorities — GOP Perspective” on November 10. Prior to that conversation, and in fact before the decision for Biden was confirmed, we asked Mr. Hoppe for his perspective.] Vice President Biden is leading in the polls in a number of contested states and […]

The Election of Joe Biden: Democrat Perspective

The election of Joe Biden brings a Democrat into office even as the Republicans maintain control of the Senate, which could slow or moderate policymaking in Washington. To understand the current situation, GLG sat down on November 12 with Jeff Ziarko, GLG Network Member and former Senior Economic Policy Advisor to the House Ways & […]

Speaker Biographies

Hilary Malone PhD, has over 25 years of experience in global drug development, regulatory &government affairs, manufacturing and commercialization within the biopharma industry. Hilary hassignificant board level and executive committee experience including large scale organizationalrestructuring/transformation/integration, major M&A, biotech start-up, capital raising, investorrelations and pre-IPO.​

Hilary is currently CEO of Stylus Medicine, a private genetic medicine biotech company. Previously sheserved as CEO of a Series-A neuroscience company. Prior to these roles, Hilary served as COO & EVP atValo Health Inc., Chief Regulatory Officer & SVP at Sanofi Inc., and Chief Regulatory Officer & SVP atPfizer and Wyeth. Previous experience also includes senior regulatory and drug development roles atReata Pharmaceuticals Inc., AstraZeneca plc and GlaxoSmithKline plc.​

Hilary also serves on the Board of Directors of Hansa Biopharma and Adthera Bio. Hilary holds a PhD inMolecular Neuropharmacology and a BSc in Physiology.

Dr. Thomas Lönngren is Director at his own company PharmaExec Consulting AB. He is the Chairman of the Board of directors at Egetis Therapeutics AB, Sweden. Dr Lönngren also serves as board member at Compass Pathways PLC, London UK and NDA Group, Sweden. He acts as advisor to the following companies and organizations: NDA group, Sweden, Sweden, Artis Venture, San Francisco, US, Fujimoto Japan, Skin2Neuron Pty Ltd, Sydney, Australia, US, Special advisor to the Centre for Innovation in Regulatory Science (CIRS), London UK. From 2001 until2011, Mr.Lönngren served as the Executive Director of the European Medical Agency. He was previously Deputy General Director of the Swedish Medical Product Agency until 2000. He has a degree in pharmacy and MSc in Social and Regulatory Pharmacy from Uppsala University. He is also an Honorary Member of the Royal Pharmaceutical Society of Great Britain, Honorary Fellow of the Royal College of Physicians in Great Britain, Honorary Doctorate from the University of Uppsala, Honorary Doctorate from University of Bath, UK.

Speaker Biographies

Marie-Anne Aymerich

Marie-Anne has built a portfolio of senior advisory and non-executive roles, following a successful international career in the FMCG and Luxury sectors. She is a non-executive director of Haleon, a FTSE100 company listed in 2022 after the demerger from GSK. She is also chairwoman of Haleon Environment and Societal Sustainability committee. She is the executive director of the Pierre Fabre Group where she also sits on the Strategic Committee, and she is a Board Member of The Academy of St. Martin-in-the-Fields, one of the world’s most prestigious chamber orchestras. She is also an angel investor and focuses her time and investments on start-ups with the strongest purpose and impact.

Marie-Anne is also a regular lecturer at HEC Paris on purposeful leadership, and she has created a serious game called “Planet Purpose” to upskill people on sustainability and purpose. Throughout her 35year executive career she delivered a strong track-record of business performance and growth in brands and portfolio in both developed and emerging economies.

As a senior leader with Unilever, she led a number of different personal care categories across France, Spain and the USA – including managing the Dove brand worldwide and culminating in leading Unilever’s global Oral Care division. She also worked for LVMH as Brand General Manager of Dior Perfumes and Cosmetics worldwide. Marie-Anne was also Vice-President of Imagine for Margo – Children with Cancer for ten years, a charity she helped found in 2011 with the goal of eradicating children’s cancer. The charity is the #1 charity focused on child cancer in France and has fundraised more than €14m since its creation. Marie-Anne is a graduate from HEC Paris. She is married and has two children aged 29 and 26.

Patrick Jephson

Patrick Jephson is a consultant, journalist, broadcaster and New York Times bestselling author, based in Washington D.C. He is a published authority on corporate and personal branding and crisis communications, addressing conferences worldwide as well as events at the U.S. State Department, the American University and the Annenberg School for Communication and Journalism.

With more than twenty-five years’ experience in the government, luxury and family office sectors, Patrick’s portfolio has included globally admired brands as well as national agencies and NGOs. He has also worked on reputation and legacy briefs with European, Middle Eastern and Asian families, including royalty. He now writes, presents, and advises on factual and drama TV programs, appearing on every major American and many international networks. He was recently an expert consultant to the award-winning Netflix series The Crown and provided live commentary on the Coronation of King Charles.

Patrick owes much of his practical communications and protocol experience to Princess Diana, who chose him to be her equerry and only private secretary/chief of staff. He served the Princess for eight years, responsible for all aspects of her public life, global humanitarian initiatives, and private organization. Having worked for an internationally high-profile woman (and as the father of two professionally successful daughters) he feels a special affinity for cross-cultural, gender and perception issues.

Patrick was born and raised in Ireland and holds a master’s degree in political science from Cambridge University. As an officer in the British Royal Navy, he served all over the world before being selected for royal duty. He is a citizen of the U.K., U.S.A., Ireland, and Canada.